Edwin Choy

14.2k total citations · 3 hit papers
203 papers, 8.5k citations indexed

About

Edwin Choy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Edwin Choy has authored 203 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Pulmonary and Respiratory Medicine, 87 papers in Oncology and 63 papers in Molecular Biology. Recurrent topics in Edwin Choy's work include Sarcoma Diagnosis and Treatment (120 papers), Bone Tumor Diagnosis and Treatments (47 papers) and Vascular Tumors and Angiosarcomas (26 papers). Edwin Choy is often cited by papers focused on Sarcoma Diagnosis and Treatment (120 papers), Bone Tumor Diagnosis and Treatments (47 papers) and Vascular Tumors and Angiosarcomas (26 papers). Edwin Choy collaborates with scholars based in United States, China and Canada. Edwin Choy's co-authors include Francis J. Hornicek, Henry J. Mankin, Zhenfeng Duan, David C. Harmon, Gregory M. Coté, Mark R. Philips, Thomas F. DeLaney, Vi K. Chiu, Jacson Shen and Zhenfeng Duan and has published in prestigious journals such as New England Journal of Medicine, Cell and The Lancet.

In The Last Decade

Edwin Choy

199 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endomembrane Trafficking of Ras

1999 624 citations Edwin Choy et al. profile →
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

2016 539 citations Edwin Choy, George D. Demetri et al. profile →
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

2013 430 citations Edwin Choy et al. profile →

Peers

Countries citing papers authored by Edwin Choy

Since Specialization

Citations

This map shows the geographic impact of Edwin Choy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Choy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Choy more than expected).

Fields of papers citing papers by Edwin Choy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Choy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Choy. The network helps show where Edwin Choy may publish in the future.

Co-authorship network of co-authors of Edwin Choy

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Choy. A scholar is included among the top collaborators of Edwin Choy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Choy. Edwin Choy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study. 2024 ·Journal of Clinical Oncology ·David S. Shulman, Kelly Klega, Nan Chen, (unknown), (unknown), Edwin Choy, Thomas F. Cash, Kris Ann P. Schultz, Leo Mascarenhas, Rochelle Bagatell, Brian Turpin, Bhuvana A. Setty, (unknown), Douglas S. Hawkins, Michael W. Bishop, Avanthi Tayi Shah, Luke Maese, Wendy B. London, Steven G. DuBois, Brian D. Crompton	1
2	Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates 2024 ·Clinical Cancer Research ·Candace L. Haddox, Michael J. Nathenson, Emanuele Mazzola, Jia‐Ren Lin, Joanna Bagińska, Allison Nau, Jason L. Weirather, Edwin Choy, Adrián Mariño‐Enríquez, Jeffrey A. Morgan, Gregory M. Coté, Priscilla Merriam, Andrew J. Wagner, Peter K. Sorger, Sandro Santagata, Suzanne George	17
3	Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma 2023 ·Cancer Medicine ·David S. Shulman, Priscilla Merriam, Edwin Choy, Lillian M. Guenther, Kerri L. Cavanaugh, Pei‐Chi Kao, (unknown), (unknown), (unknown), Emma Barker, Kelly Klega, Kimberly Stegmaier, Brian D. Crompton, Wendy B. London, Steven G. DuBois	21
4	SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) 2023 ·Clinical Cancer Research ·Sujana Movva, (unknown), Elizabeth A. Handorf, Edwin Choy, Priscilla Merriam, Douglas B. Flieder, Kathy Q. Cai, Yan Zhou, Eric D. Tetzlaff, (unknown), Emma Barker, (unknown), (unknown), Lori Rink, Margaret von Mehren, Suzanne George	14
5	A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report 2023 ·The Oncologist ·Daniel E. McLoughlin, (unknown), Edwin Choy, Gregory A. Coté, Xīn Gào, Dejan Juric, Kerry L. Reynolds	0
6	Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity 2023 ·Science Advances ·Rajendran Sanalkumar, Rui Dong, (unknown), Yu‐Hang Xing, Sowmya Iyer, Igor Letovanec, Stefano La Rosa, Giovanna Finzi, (unknown), Roberto Papait, Ivan Chebib, G. Petur Nielsen, Raffaele Renella, Gregory M. Coté, Edwin Choy, Martin J. Aryee, Kimberly Stegmaier, Ivan Stamenkovic, Miguel N. Rivera, Nicolò Riggi	17
7	A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma 2022 ·Clinical Cancer Research ·Matthew Ingham, Shing M. Lee, Brian A. Van Tine, Edwin Choy, Jay Oza, (unknown), (unknown), (unknown), Gregory M. Coté, (unknown), (unknown), (unknown), (unknown), Emmanuel Petricoin, Gary K. Schwartz	8
8	Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution 2019 ·Sarcoma ·Ruoyu Miao, Edwin Choy, Kevin A. Raskin, Joseph H. Schwab, G. Petur Nielsen, Vikram Deshpande, Ivan Chebib, Thomas F. DeLaney, Francis J. Hornicek, Gregory M. Coté, Yen-Lin E. Chen	27
9	Expression and Therapeutic Potential of SOX9 in Chordoma 2017 ·Clinical Cancer Research ·(unknown), Cassandra C. Garbutt, Dimitrios Spentzos, Edwin Choy, Francis J. Hornicek, Zhenfeng Duan	41
10	Evaluation of P‐glycoprotein (Pgp) expression in human osteosarcoma by high‐throughput tissue microarray 2016 ·Journal of Orthopaedic Research® ·Yan Gao, Yunfei Liao, Jacson Shen, Yong Feng, Edwin Choy, Gregory M. Coté, David C. Harmon, Henry J. Mankin, Francis J. Hornicek, Zhenfeng Duan	14
11	NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo 2015 ·Gynecologic Oncology ·Xiaoqian Yang, Yong Feng, Yan Gao, Jacson Shen, Edwin Choy, Gregory M. Coté, David C. Harmon, Zhan Zhang, Henry J. Mankin, Francis J. Hornicek, Zhenfeng Duan	10
12	Programmed Cell Death Ligand 1 Expression in Osteosarcoma 2014 ·Cancer Immunology Research ·Jacson Shen, Gregory M. Coté, Edwin Choy, Pei Yang, David C. Harmon, Joseph H. Schwab, G. Petur Nielsen, Ivan Chebib, Soldano Ferrone, Xinhui Wang, Yangyang Wang, Henry J. Mankin, Francis J. Hornicek, Zhenfeng Duan	154
13	Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial 2012 ·Journal of Clinical Oncology ·Suzanne George, Qian Wang, Michael C. Heinrich, Christopher L. Corless, Mei‐Jun Zhu, James E. Butrynski, Jeffrey A. Morgan, Andrew J. Wagner, Edwin Choy, William D. Tap, Jeffrey T. Yap, Annick D. Van den Abbeele, Judith Manola, Sarah Solomon, Jonathan A. Fletcher, Margaret von Mehren, George D. Demetri	200
14	Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation 2012 ·Clinical Cancer Research ·Zhenfeng Duan, Jianming Zhang, Edwin Choy, David C. Harmon, Xianzhe Liu, Petur Nielsen, Henry J. Mankin, Nathanael S. Gray, Francis J. Hornicek	60
15	Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines. 2011 ·PubMed ·Yang Cao, Edwin Choy, Francis J. Hornicek, Kirkham B. Wood, Joseph H. Schwab, Xianzhe Liu, Henry J. Mankin, Zhenfeng Duan	21
16	Effects of Siltuximab on the IL-6–Induced Signaling Pathway in Ovarian Cancer 2010 ·Clinical Cancer Research ·Yuqi Guo, Jeffrey A. Nemeth, Conan J O O’Brien, Michiro Susa, Xianzhe Liu, Zhan Zhang, Edwin Choy, Henry J. Mankin, Francis J. Hornicek, Zhenfeng Duan	87
17	Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking 2010 ·Molecular Cancer Therapeutics ·Michiro Susa, Edwin Choy, Xianzhe Liu, Joseph H. Schwab, Francis J. Hornicek, Henry J. Mankin, Zhenfeng Duan	26
18	Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines 2009 ·Molecular Cancer Therapeutics ·Zhenfeng Duan, Edwin Choy, David C. Harmon, Yang Cao, (unknown), Joseph H. Schwab, Henry J. Mankin, Francis J. Hornicek	76
19	A novel target for treatment of chordoma: signal transducers and activators of transcription 3 2009 ·Molecular Cancer Therapeutics ·Yang Cao, Joseph H. Schwab, Andrew J. Schoenfeld, Francis J. Hornicek, Kirkham B. Wood, G. Petur Nielsen, Edwin Choy, Henry J. Mankin, Zhenfeng Duan	43
20	Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer 2008 ·Molecular Cancer Therapeutics ·Zhenfeng Duan, Edward J. Weinstein, Diana Ji, (unknown), Edwin Choy, Henry J. Mankin, Francis J. Hornicek	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact